MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions

• Published in: Non-coding RNA research Vol. 5; no. 1; pp. 11 - 21
• Main Authors: ElKhouly, Aisha M., Youness, R.A., Gad, M.Z.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2020; KeAi Publishing; KeAi Communications Co., Ltd
• Subjects: Breast cancer; Liver cancer; long non-coding RNAs; Lung cancer; miR-486-3p; miR-486-5p; Xist; Liver cancer; miR-486-5p; miR-486-3p; Lung cancer; Breast cancer; Xist; long non-coding RNAs
• ISSN: 2468-0540; 2468-0540
• DOI: 10.1016/j.ncrna.2020.01.001

Despite historically known as “junk” DNA, nowadays non-coding RNA transcripts (ncRNAs) are considered as fundamental players in various physiological and pathological conditions. Nonetheless, any alteration in their expression level has been reported to be directly associated with the incidence and aggressiveness of several diseases. MicroRNAs (miRNAs) are the well-studied members of the ncRNAs family. Several reports have highlighted their crucial roles in the post-transcriptional manipulation of several signaling pathways in different pathological conditions. In this review, our main focus is the multifaceted microRNA-486 (miR-486). miR-486-5p and miR-486-3p have been reported to have central roles in several types oncological and non-oncological conditions such as lung, liver, breast cancers and autism, intervertebral disc degeneration and metabolic syndrome, respectively. Moreover, we spotted the light onto the pleiotropic role of miR-486-5p in acting as competing endogenous RNA with other members of ncRNAs family such as long non-coding RNAs.